Learn About Spinal Muscular Atrophy Type 2

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Spinal Muscular Atrophy Type 2 Local Doctors?
Elite
Highly rated in
40
conditions

Università Cattolica Del Sacro Cuore

Rome, IT 

Eugenio Mercuri is in Rome, Italy. Mercuri is rated as an Elite expert by MediFind in the treatment of Spinal Muscular Atrophy Type 2. He is also highly rated in 40 other conditions, according to our data. His top areas of expertise are Spinal Muscular Atrophy, Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Primary Lateral Sclerosis.

Elite
Highly rated in
16
conditions

Università Cattolica Del Sacro Cuore

Rome, IT 00168

Marika Pane is in Rome, Italy. Pane is rated as an Elite expert by MediFind in the treatment of Spinal Muscular Atrophy Type 2. She is also highly rated in 16 other conditions, according to our data. Her top areas of expertise are Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2, Spinal Muscular Atrophy Type 1, and Becker Muscular Dystrophy.

 
 
 
 
Learn about our expert tiers
Learn more
Elite
Highly rated in
7
conditions

Università Cattolica Del Sacro Cuore

Rome, IT 

Giorgia Coratti is in Rome, Italy. Coratti is rated as an Elite expert by MediFind in the treatment of Spinal Muscular Atrophy Type 2. She is also highly rated in 7 other conditions, according to our data. Her top areas of expertise are Spinal Muscular Atrophy Type 2, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy, and Spinal Muscular Atrophy Type 1.

What are the Latest Advances for Spinal Muscular Atrophy Type 2?
A Case Report of Systemic Intoxication Following Onabotulinum Toxin A Injections Into the Salivary Glands in a Patient With Spinal Muscular Atrophy Type 1.
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.
Tired of the same old research?
Check Latest Advances
Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis.
What are the latest Spinal Muscular Atrophy Type 2 Clinical Trials?
Phenotypes, Biomarkers and Pathophysiology in Spastic Ataxias
Match to trials
Find the right clinical trials for you in under a minute
Get started
Biomarker Development for Muscular Dystrophies